Analysis and Commentary Guest User 10/1/20 Analysis and Commentary Guest User 10/1/20 Understanding the Short-Term CR Read More Advocacy at a Glance Guest User 9/25/20 Advocacy at a Glance Guest User 9/25/20 FDA Will Begin Fiscal Year 2021 With CR Funding Read More Analysis and Commentary Guest User 10/5/18 Analysis and Commentary Guest User 10/5/18 Will This Year’s Lame Duck Conduct “Business as Usual”? Read More Advocacy at a Glance Guest User 10/5/18 Advocacy at a Glance Guest User 10/5/18 October 1 Came and Went: CR Covers FDA Until December 7 Read More Analysis and Commentary Guest User 7/13/18 Analysis and Commentary Guest User 7/13/18 Our Advocacy Remains an Imperative for Strong Funding Read More Advocacy at a Glance Guest User 1/27/18 Advocacy at a Glance Guest User 1/27/18 Shutdown Ends, but Without a Deal; Next CR Runs Until February 8 and more Read More Analysis and Commentary Guest User 12/22/17 Analysis and Commentary Guest User 12/22/17 From This Week's CR into FY 19: More Alliance Priorities Read More Advocacy at a Glance Guest User 12/22/17 Advocacy at a Glance Guest User 12/22/17 Continuing Resolution Funds Federal Government through January 19 and more Read More Advocacy at a Glance Guest User 11/10/17 Advocacy at a Glance Guest User 11/10/17 Why Does the Alliance Advocate for Funding All of FDA and more Read More Analysis and Commentary Guest User 9/8/17 Analysis and Commentary Guest User 9/8/17 Some Shocks -- Some Pleasant; Some Less So Read More Analysis and Commentary Guest User 10/23/15 Analysis and Commentary Guest User 10/23/15 The Ryan Era? One Step Closer to the End-Game! Read More
Analysis and Commentary Guest User 10/1/20 Analysis and Commentary Guest User 10/1/20 Understanding the Short-Term CR Read More
Advocacy at a Glance Guest User 9/25/20 Advocacy at a Glance Guest User 9/25/20 FDA Will Begin Fiscal Year 2021 With CR Funding Read More
Analysis and Commentary Guest User 10/5/18 Analysis and Commentary Guest User 10/5/18 Will This Year’s Lame Duck Conduct “Business as Usual”? Read More
Advocacy at a Glance Guest User 10/5/18 Advocacy at a Glance Guest User 10/5/18 October 1 Came and Went: CR Covers FDA Until December 7 Read More
Analysis and Commentary Guest User 7/13/18 Analysis and Commentary Guest User 7/13/18 Our Advocacy Remains an Imperative for Strong Funding Read More
Advocacy at a Glance Guest User 1/27/18 Advocacy at a Glance Guest User 1/27/18 Shutdown Ends, but Without a Deal; Next CR Runs Until February 8 and more Read More
Analysis and Commentary Guest User 12/22/17 Analysis and Commentary Guest User 12/22/17 From This Week's CR into FY 19: More Alliance Priorities Read More
Advocacy at a Glance Guest User 12/22/17 Advocacy at a Glance Guest User 12/22/17 Continuing Resolution Funds Federal Government through January 19 and more Read More
Advocacy at a Glance Guest User 11/10/17 Advocacy at a Glance Guest User 11/10/17 Why Does the Alliance Advocate for Funding All of FDA and more Read More
Analysis and Commentary Guest User 9/8/17 Analysis and Commentary Guest User 9/8/17 Some Shocks -- Some Pleasant; Some Less So Read More
Analysis and Commentary Guest User 10/23/15 Analysis and Commentary Guest User 10/23/15 The Ryan Era? One Step Closer to the End-Game! Read More
